Globus Medical Files 8-K on Financial Condition and Operations
Ticker: GMED · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1237831
| Field | Detail |
|---|---|
| Company | Globus Medical Inc (GMED) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, 8-K
TL;DR
**Globus Medical just filed an 8-K on their financial results, keep an eye out for the full details!**
AI Summary
Globus Medical, Inc. filed an 8-K on February 20, 2024, reporting on its results of operations and financial condition. The filing indicates the company's principal executive offices are located at 2560 General Armistead Avenue, Audubon, PA 19403, with a business phone number of 610-930-1800. This current report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing provides an update on Globus Medical's operational and financial status, offering transparency to investors and the market regarding its performance.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial condition and operations, not indicating any immediate adverse events.
Key Players & Entities
- GLOBUS MEDICAL, INC. (company) — Registrant
- February 20, 2024 (date) — Date of earliest event reported
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403 (address) — Principal executive offices
- 610-930-1800 (phone_number) — Registrant's telephone number
- DELAWARE (state) — State of incorporation
FAQ
What is the purpose of this 8-K filing by Globus Medical, Inc.?
The 8-K filing by Globus Medical, Inc. is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is February 20, 2024.
What is the business address of Globus Medical, Inc. as stated in the filing?
The business address of Globus Medical, Inc. is 2560 General Armistead Avenue, Audubon, PA 19403.
What is the Commission File Number for Globus Medical, Inc.?
The Commission File Number for Globus Medical, Inc. is 001-35621.
Under which act was this 8-K filed?
This 8-K was filed under the 1934 Act, specifically pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-02-20 16:35:42
Filing Documents
- gmed-20240220x8k.htm (8-K) — 70KB
- gmed-20240220xex99_1.htm (EX-99.1) — 1068KB
- 0001562762-24-000030.txt ( ) — 1293KB
- gmed-20240220.xsd (EX-101.SCH) — 2KB
- gmed-20240220_lab.xml (EX-101.LAB) — 12KB
- gmed-20240220_pre.xml (EX-101.PRE) — 11KB
- gmed-20240220x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 20, 2024, we issued a press release reporting, among other things, our sales and operating results for the three- and twelve-month periods ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report. In accordance with general instruction B.2 to Form 8-K, the information included in this Item 2.02, and the exhibits attached hereto, shall be deemed to be "furnished" and shall not be deemed to be "filed" with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated February 20, 2024 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBUS MEDICAL, INC. (Registrant) Dated: February 20, 2024 /s/ KEITH PFEIL Keith Pfeil Chief Financial Officer and Chief Operating Officer Chief Accounting Officer Senior Vice President (Principal Financial Officer)